Comment Period Extended to 3/23/2015 for Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
1 study found for:    19228745 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Completed Vaccine Therapy With or Without Biological Therapy in Treating Patients With Metastatic Melanoma
Condition: Melanoma (Skin)
Interventions: Biological: MART-1 antigen;   Biological: gp100 antigen;   Biological: incomplete Freund's adjuvant;   Biological: recombinant interferon alfa;   Biological: sargramostim;   Biological: tyrosinase peptide

Indicates status has not been verified in more than two years